The Centers for Medicare & Medicaid Services violated the Administrative Procedure Act by allowing a single phone call made by a contractor to determine a Medicare Advantage star rating, a federal judge ruled. 

The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing. 

41 members of the upper chamber recently penned a letter to colleagues, contending that inaction could impact seniors’ access to care. 

Embolization is a safe, cost-effective alternative to a hysterectomy, but patients are not using the IR service in some geographies. 

The Food and Drug Administration approval comes amid growing interest in remote-scan technology following the COVID pandemic. 

Fevers of unknown origin account for around 2% of hospitalizations and can present significant diagnostic challenges for providers.

Accrediting body IAC said revisions help imaging facilities ensure the safe delivery of MRIs, including when key personnel are located off-site.

Acoramidis, a selective transthyretin stabilizer being sold under the brand name Attruby, is now the second ATTR-CM medication to gain FDA approval.